ADPT Adaptive Bio posts narrower than expected Q4 2025 loss shares rise 232 percent on investor optimism Illumina ILMN Management Strategy Q4 2025 Better Than Expected CFND C1 Fund lays out multisegment growth targets alongside its latest quarterly earnings release